CymitQuimica logo

Pancreastatin (33-48) (human) trifluoroacetate salt

CAS:

Ref. 3D-FP109859

1mg
860.00€
2mg
1,195.00€
5mg
2,546.00€
Pancreastatin (33-48) (human) trifluoroacetate salt
Biosynth

Product Information

Name:Pancreastatin (33-48) (human) trifluoroacetate salt
Synonyms:
  • H-Glu-Glu-Glu-Glu-Glu-Met-Ala-Val-Val-Pro-Gln-Gly-Leu-Phe-Arg-Gly-NH2 H-EEEEEMAVVPQGLFRG-NH2
Brand:Biosynth
Description:Pancreastatin (33-48) is a synthetic, acidic, sulfated peptide that has been shown to have high activity against pancreatic cancer cells. Pancreastatin (33-48) has been synthesized by reacting an oligopeptide with glutamic acid and aspartic acid. The N-terminal of this peptide is amidated and contains a sulfate group. This molecule has been purified by SDS-polyacrylamide gel electrophoresis and the sulfate fractionation method. Pancreastatin (33-48) is able to inhibit the proliferation of pancreatic tumor cells in vitro, but it does not appear to be cytotoxic to normal pancreatic cells. In addition, pancreastatin (33-48) has also been shown to decrease tumor growth in vivo in mice bearing a transplanted human pancreatic tumor.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:1,819 g/mol
Formula:C78H123N21O27S
Purity:Min. 95%

Technical inquiry about: Pancreastatin (33-48) (human) trifluoroacetate salt

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.